venBio Global Strategic GP II, Ltd.
CIK 1729408 · last filed 2022-05-12
venBio Global Strategic GP II, Ltd. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider sold $8.4M of CMPI on May 12, 2022. Across all open-market trades the lifetime net is −$74.5M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
6
-$74.55M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | 10%+ Owner | 2,287,580 | $10.50 | $24.02M | -$15.10M | 2 | 2022-05-12 |
| Akero Therapeutics, Inc. (AKRO) Delisted | 10%+ Owner | 3,160,319 | $54.65 | $172.71M | -$59.45M | 4 | 2020-03-06 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-12 | Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | Sell (S) | −804,505 | -$8.36M | EDGAR |
| 2022-04-26 | Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | Sell (S) | −648,905 | -$6.74M | EDGAR |
| 2020-03-06 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −229,750 | -$5.46M | EDGAR |
| 2020-03-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −108,990 | -$2.47M | EDGAR |
| 2020-01-14 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −2,470,000 | -$49.97M | EDGAR |
| 2020-01-10 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −78,385 | -$1.56M | EDGAR |